FFP
ANGO icon

FourThought Financial Partners’s AngioDynamics ANGO Stock Holding History

FourThought Financial Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,168
Closed -$169K – 395
2025
Q4 		$169K Buy
+13,168
New +$163K 0.01% 473

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

FourThought Financial Partners's ANGO Position: Q1 2026 in Review

FourThought Financial Partners sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 13,168 shares — an estimated $169K sold.

FourThought Financial Partners first reported a position in ANGO in Q4 2025 and held it in 1 quarter. The position peaked at $169K in Q4 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • FourThought Financial Partners reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • FourThought Financial Partners sold 13,168 AngioDynamics shares in Q1 2026, an estimated $169K.
  • FourThought Financial Partners first reported a position in AngioDynamics in Q4 2025 and held it in 1 quarter.
  • FourThought Financial Partners's AngioDynamics position peaked at $169K in Q4 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.